High dose idarubicine, busulphan and melphalan conditioning regimen for lymphoproliferative disorders

被引：0
|
作者：
Trasarti, S [1 ]
Meloni, G [1 ]
Capria, S [1 ]
Bongarzoni, V [1 ]
Ferrazza, G [1 ]
Iodice, F [1 ]
Proia, A [1 ]
Trisolini, SM [1 ]
Mandelli, F [1 ]
机构：
[1] Univ Rome La Sapienza, Dipartimento Biotecnol Cellulari & Ematol, Roma, Italy
来源：
BONE MARROW TRANSPLANTATION | 1998年 / 21卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
352
引用
收藏
页码：S100 / S100
页数：1
相关论文
共 50 条
  • [1] High-dose idarubicin, busulphan and melphalan conditioning regimen for autograft in multiple myeloma
    Capria, S
    Petrucci, MT
    Ferrazza, G
    Ribersani, M
    Torromeo, C
    Trisolini, SM
    Mandelli, F
    Meloni, G
    BONE MARROW TRANSPLANTATION, 2002, 29 : S97 - S97
  • [2] High-dose idarubicine, busulphan and melphalan as conditioning for autologous blood stem cell transplantation in multiple myeloma. A feasibility study
    Meloni, G
    Capria, S
    Trasarti, S
    Ferrazza, G
    Micozzi, A
    Petrucci, MT
    Simone, F
    Trisolini, SM
    Mandelli, F
    BONE MARROW TRANSPLANTATION, 2000, 26 (10) : 1045 - 1049
  • [3] High-dose idarubicine, busulphan and melphalan as conditioning for autologous blood stem cell transplantation in multiple myeloma. A feasibility study
    G Meloni
    S Capria
    S Trasarti
    G Ferrazza
    A Micozzi
    MT Petrucci
    F Simone
    SM Trisolini
    F Mandelli
    Bone Marrow Transplantation, 2000, 26 : 1045 - 1049
  • [4] High-dose idarubicine, busulphan and melphalan for autologous stem cell transplantation in multiple myeloma. Comparison with an historical control
    Capria, S
    Ribersani, M
    Ferrazza, G
    Micozzi, A
    Petrucci, MT
    Simone, F
    Torromeo, MC
    Trisolini, SM
    Mandelli, F
    Meloni, G
    BONE MARROW TRANSPLANTATION, 2003, 31 : S81 - S82
  • [5] HIGH-DOSE BUSULFAN AND MELPHALAN AS CONDITIONING REGIMEN PRIOR TO TRANSPLANTATION
    MARIT, G
    CONY, P
    DAVID, B
    BROUSTET, A
    REIFFERS, J
    BONE MARROW TRANSPLANTATION, 1988, 3 : 78 - 78
  • [6] High dose Melphalan/Thiotepa conditioning regimen for resistant lymphoma.
    Kirschbaum, MH
    Gur, O
    Nadav, L
    Naparstek, E
    BLOOD, 2002, 100 (11) : 477B - 477B
  • [7] Fludarabine plus high dose melphalan or busulphan are reduced intensity but truly myeloablative conditioning regimens
    Pardo Gonzalez, C.
    Gonzalez, A.
    Fernandez, R.
    Gonzalez, A.
    Palomo, P.
    Gonzalez, S.
    Arija, E.
    Martinez-Mugica, C.
    Rayon, C.
    Vallejo, C.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S237 - S238
  • [8] HIGH-DOSE MELPHALAN IS A SAFE CONDITIONING REGIMEN IN ELDERLY PATIENTS WITH MULTIPLE MYELOMA
    Cangini, D.
    Cerchione, C.
    Giannini, M. B.
    Di Battista, V.
    Frabetti, F.
    Petracci, E.
    Ronconi, S.
    Martinelli, G.
    HAEMATOLOGICA, 2019, 104 : 163 - 163
  • [9] Fludarabine and low dose of melphalan as effective conditioning regimen for allogeneic stem cell transplantation in lymphoproliferative diseases and multiple myeloma
    Yanez, L.
    Bermudez, A.
    Perez, G.
    Diez, Z.
    Richard, C.
    Iriondo, A.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S404 - S405
  • [10] BUSULPHAN-MELPHALAN VERSUS CARBOPLATIN-ETOPOSIDE-MELPHALAN CONDITIONING REGIMEN IN CHILDREN WITH NEUROBLASTOMA UNDERWENT AUTOLOGOUS STEM CELL TRANSPLANTATION
    Atas, E.
    Kesik, V.
    Babacan, O.
    Korkmazer, N.
    BONE MARROW TRANSPLANTATION, 2014, 49 : S206 - S206
12345